← All candidates
105 insider filings on record.
105 filings on record.
AXSMAxsome Therapeutics, Inc.
NasdaqGM · Healthcare · $10.86B
$216.58
-5.78% today
105 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 38 sells◆ 8 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$10.86B
Float
44.5M
85% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
41.2
Price / sales
14.0
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Coleman Mark
Bought $101.8K on Sep 8 — 800 sh @ $127.20, held direct, 1.7% of their stake.
1 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
100 more transactions on Pro →Context
Wall St
$270.28 avg target
+24.8% vs today · 21 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$1.26 act−$0.40
Q4 '25−$0.56 act+$0.17
Q3 '25−$0.94 act−$0.04
Q2 '25−$0.97 act+$0.12
Coverage
The file stays open
105 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice